
Germany’s “traffic light” coalition is no more; but when it comes to cannabis, its legacy is here to stay. Since April 1, 2024 and for the foreseeable future, doctors can now prescribe it, creating tailwinds for the country’s medical cannabis startups.
North American players took notice. In June of this year, NASDAQ-listed cannabis producer Organigram Holdings invested in Berlin-based cannabis company Sanity Group with hopes of gaining a foothold in what it sees as a high-growth market.